These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3333623)

  • 1. Stabilizing blood glucose with a novel medical expert system.
    Lougheed WD; Schiffrin A; Albisser AM
    Biosensors; 1987-1988; 3(6):381-9. PubMed ID: 3333623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of subcutaneous insulin management protocols and order sets in inpatient diabetes management.
    Houlden RL; Moore S; Cornish W; Tiwana K
    Can J Diabetes; 2014 Apr; 38(2):101-17. PubMed ID: 24690505
    [No Abstract]   [Full Text] [Related]  

  • 3. A prototype of a new noninvasive device to detect nocturnal hypoglycemia in adolescents with type 1 diabetes--a pilot study.
    Schechter A; Eyal O; Zuckerman-Levin N; Amihai-Ben-Yaacov V; Weintrob N; Shehadeh N
    Diabetes Technol Ther; 2012 Aug; 14(8):683-9. PubMed ID: 22690891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can hypoglycaemia be predicted before its onset?
    Maggs D
    Diabetologia; 1996 May; 39(5):615-7. PubMed ID: 8801160
    [No Abstract]   [Full Text] [Related]  

  • 5. The Incremental Benefits of the Predictive Low-Glucose Suspend Function Compared to the Low-Glucose Suspend Function as Automation Against Hypoglycemia in Sensor-Augmented Pump Therapy.
    Beato-Víbora PI; Gil-Poch E; Galán-Bueno L; Lázaro-Martín L; Arroyo-Díez FJ
    J Diabetes Sci Technol; 2018 Nov; 12(6):1241-1243. PubMed ID: 30058373
    [No Abstract]   [Full Text] [Related]  

  • 6. Validation of a metabolic prototype to assist in the treatment of insulin-dependent diabetes mellitus.
    Lehmann ED; Deutsch T; Roudsari AV; Carson ER; Sonksen PH
    Med Inform (Lond); 1993; 18(2):83-101. PubMed ID: 8231426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining rule-based reasoning and mathematical modelling in diabetes care.
    Lehmann ED; Deutsch T; Carson ER; Sönksen PH
    Artif Intell Med; 1994 Apr; 6(2):137-60. PubMed ID: 8049754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining statistical, rule-based, and physiologic model-based methods to assist in the management of diabetes mellitus.
    Berger MP; Gelfand RA; Miller PL
    Comput Biomed Res; 1990 Aug; 23(4):346-57. PubMed ID: 2203598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-Clinic Evaluation of the MiniMed 670G System "Suspend Before Low" Feature in Children with Type 1 Diabetes.
    Wood MA; Shulman DI; Forlenza GP; Bode BW; Pinhas-Hamiel O; Buckingham BA; Kaiserman KB; Liljenquist DR; Bailey TS; Shin J; Huang S; Chen X; Cordero TL; Lee SW; Kaufman FR
    Diabetes Technol Ther; 2018 Nov; 20(11):731-737. PubMed ID: 30299976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New technologies in the treatment of type 1 diabetes.
    Schmidt S
    Dan Med J; 2013 Nov; 60(11):B4746. PubMed ID: 24192247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy evaluation of a new real-time continuous glucose monitoring algorithm in hypoglycemia.
    Mahmoudi Z; Jensen MH; Dencker Johansen M; Christensen TF; Tarnow L; Christiansen JS; Hejlesen O
    Diabetes Technol Ther; 2014 Oct; 16(10):667-78. PubMed ID: 24918271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial.
    Forlenza GP; Li Z; Buckingham BA; Pinsker JE; Cengiz E; Wadwa RP; Ekhlaspour L; Church MM; Weinzimer SA; Jost E; Marcal T; Andre C; Carria L; Swanson V; Lum JW; Kollman C; Woodall W; Beck RW
    Diabetes Care; 2018 Oct; 41(10):2155-2161. PubMed ID: 30089663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The bionic pancreas: novel perspectives on insulin replacement therapies.
    Denecke C
    Transplantation; 2015 Feb; 99(2):268-9. PubMed ID: 25651115
    [No Abstract]   [Full Text] [Related]  

  • 14. "Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients.
    Biester T; Kordonouri O; Holder M; Remus K; Kieninger-Baum D; Wadien T; Danne T
    Diabetes Technol Ther; 2017 Mar; 19(3):173-182. PubMed ID: 28099035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Avoiding nocturnal hypoglycemia: consideration of an extra injection at bedtime.
    Norris AW; Laffel LM
    Ann Intern Med; 2002 Apr; 136(7):547-9. PubMed ID: 11926791
    [No Abstract]   [Full Text] [Related]  

  • 16. [Insulin and insulin treatment 1989].
    Berger W
    Schweiz Rundsch Med Prax; 1989 Oct; 78(43):1179-82. PubMed ID: 2682924
    [No Abstract]   [Full Text] [Related]  

  • 17. Administration of neutral protamine Hagedorn insulin at bedtime versus with dinner in type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control. A randomized, controlled trial.
    Fanelli CG; Pampanelli S; Porcellati F; Rossetti P; Brunetti P; Bolli GB
    Ann Intern Med; 2002 Apr; 136(7):504-14. PubMed ID: 11926785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Night glucose control with MD-Logic artificial pancreas in home setting: a single blind, randomized crossover trial-interim analysis.
    Nimri R; Muller I; Atlas E; Miller S; Kordonouri O; Bratina N; Tsioli C; Stefanija MA; Danne T; Battelino T; Phillip M
    Pediatr Diabetes; 2014 Mar; 15(2):91-9. PubMed ID: 23944875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A coordinated control strategy for insulin and glucagon delivery in type 1 diabetes.
    Herrero P; Bondia J; Oliver N; Georgiou P
    Comput Methods Biomech Biomed Engin; 2017 Oct; 20(13):1474-1482. PubMed ID: 28929796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
    Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
    Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.